Vaxart VXRT
OTC VXRT
$0.48 -0.01 (-1.94%)
As of: Oct 21, 2026 · 12:16 PM EDT

Vaxart (VXRT) Deferred Taxes (2012 - 2013)

Updated

Vaxart (VXRT) recorded Deferred Taxes of -$1.1 million in Q4 2013.

Analysis

Vaxart (VXRT) Deferred Taxes (2012 - 2013) Analysis & Trends

For FY2013, Vaxart reported Deferred Taxes of -$1.5 million.

  • Across earlier years, Deferred Taxes came in at -$671,000 in FY2012 and -$2.02 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Vaxart 115.76 Mn 51.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 1.10 Mn
Dec 31, 2012 500,000.00
Sep 30, 2012 -100,000.00
Mar 31, 2012 -671,000.00
API Access

Vaxart Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=VXRT&period=max&api_key=YOUR_API_KEY